block: breadcrumbs
block: text
Leadership
CV6 Therapeutics is led by a multidisciplinary team of scientists, clinicians, drug developers, and experienced industry leaders with a track record of advancing innovative therapies from discovery through clinical development.
block: text
Supported by a distinguished board and advisors across oncology, translational medicine, and strategic investment, the team brings deep expertise across biology, chemistry, and clinical execution, focused on delivering meaningful impact for patients and building long-term value.
block: team-listing
block: quotes
“”
Prof. Ruth Plummer, MD
If CV6-168 performs as expected, it could fundamentally change how we use 5-FU in cancer treatment.